NeuroQure is dedicated to changing lives through trailblazing innovations, starting with the ASD Insight™ autism risk test. ASD Insight is a simple skin test pioneering early autism risk detection. This breakthrough technology enables the detection of autism risk from birth, opening doors for early detection and intervention. Research shows can lead to an average IQ improvement of over 17 points in toddlers with ASD.
| Website | http://www.neuroqure.com |
| Employees | 14 (6 on RocketReach) |
| Founded | 2023 |
| Address | 5 Mason, Irvine, California 92618, US |
| Industry | Biotechnology Research |
| Keywords | Neurological Therapies, Neuroscience, Central Nervous System, Neurological Disorders, Brain Repair, Brain Research, Biotechnology, Neurodegenerative Diseases, Drug Discovery, Brain Health, Neurological Care, Clinical Trials, Cognitive Enhancement, Cognitive Impairment, Pharmaceutical, Alzheimers Treatment, Neurological Rehabilitation, Mental Health, Multiple Sclerosis Treatment |
| Competitors | Neurocrine Biosciences, Lilly India, AstraZeneca, Biogen, Amgen, Pfizer, Novartis, Roche, Johnson & Johnson, GSK +42 more (view full list) |
Looking for a particular NeuroQure employee's phone or email?
Dave Justus is the Founder and CEO of NeuroQure.
6 people are employed at NeuroQure.
NeuroQure is based in Irvine, California.